Progress appears to have been made in mitigating long-standing shortages of doxorubicin and methotrexate. Nearly 4 months ago, the Food and Drug Administration announced measures to improve availability. Doxorubin is now available, while methotrexate continues to be available on a less predictable basis.
Read our most recent article and video on oncology drug shortages.
Check on the latest FDA update regarding methotrexate and other drug shortages. And read their blog on the issue.
